Limited Significance of Curative Surgery in Borrmann Type IV Gastric Cancer

Overview

Journal Med Oncol

Publisher Springer

Specialty Oncology

Date 2016 Jun 3

PMID 27251378

Citations 9

Authors

Eun Young Kim

Han Mo Yoo

Kyo Young Song

Cho Hyun Park

Affiliations

Soon will be listed here.

Abstract

Borrmann type IV advanced gastric cancer has a poor prognosis. Although surgical resection remains the only hope for a cure, the role of curative surgery is questionable in this type of cancer. This study defined the role of curative surgery in the prognosis of type IV gastric cancer. We analyzed 168 patients with Borrmann type IV undergoing surgery at Seoul St. Mary's Hospital from 1989 to 2010. We categorized the patients into curative (R0) and non-curative (R1, R2, and non-resection) groups. The curative and non-curative groups comprised 88 and 80 patients, respectively. The preoperative predictive value of Borrmann type IV was 50.5, and 8.9 % of the patients had microscopic resection margin involvement. The 3- to 5-year overall survival (OS) of patients in the curative group was significantly higher than that of in the non-curative group (p < 0.001). However, in a multivariate analysis, curability was not a significant predictor of survival (p = 0.187). In the curative group, the most frequent recurrence site was the peritoneum (85.7 %). Most recurrences occurred within 2 years. The role of surgery for Borrmann type IV is quite limited. Such cases have a poor prognosis even after curative surgery. In addition, microscopic resection margin involvement is frequent in type IV cancer because it is difficult to diagnose preoperatively. Therefore, multimodal diagnostic tools and treatment strategies should be developed for Borrmann type IV gastric cancer.

Citing Articles

Feasibility of laparoscopic/robot-assisted surgery for Borrmann type 4 gastric cancer: a comparison study with conventional open surgery.

Akimoto E, Kinoshita T, Yura M, Yoshida M, Okayama T, Habu T Surg Endosc. 2024; 38(6):3337-3345.

PMID: 38691134 DOI: 10.1007/s00464-024-10857-0.

Comparative Outcomes of Laparoscopic Gastrectomy and Open Gastrectomy for Scirrhous Gastric Cancer: A Multicenter Retrospective Cohort Study.

Fujita Y, Nishigori T, Kadokawa Y, Itami A, Kondo M, Hosogi H Ann Surg Open. 2023; 2(2):e063.

PMID: 37636555 PMC: 10455267. DOI: 10.1097/AS9.0000000000000063.

Gastric cancer clinical characteristics and their altered trends in South China: An epidemiological study with 2,800 cases spanning 26 years.

Wei H, Zhan X, Liao X, Li W, Chen H, Deng C Front Oncol. 2023; 13:976854.

PMID: 36824130 PMC: 9942704. DOI: 10.3389/fonc.2023.976854.

Poorly cohesive cells gastric carcinoma including signet-ring cell cancer: Updated review of definition, classification and therapeutic management.

Drubay V, Nuytens F, Renaud F, Adenis A, Eveno C, Piessen G World J Gastrointest Oncol. 2022; 14(8):1406-1428.

PMID: 36160745 PMC: 9412924. DOI: 10.4251/wjgo.v14.i8.1406.

Are Borrmann's Types of Advanced Gastric Cancer Distinct Clinicopathological and Molecular Entities? A Western Study.

Diaz Del Arco C, Ortega Medina L, Estrada Munoz L, Molina Roldan E, Ceron Nieto M, Garcia Gomez de Las Heras S Cancers (Basel). 2021; 13(12).

PMID: 34205546 PMC: 8234739. DOI: 10.3390/cancers13123081.

References

Tanigawa N, AMAYA H, Matsumura M, Lu C, Iki M . Association between tumor angiogenesis and Borrmann type 4 carcinomas of the stomach. Oncology. 1998; 55(5):461-7. DOI: 10.1159/000011896. View

Naito Y, Sakamoto N, Oue N, Yashiro M, Sentani K, Yanagihara K . MicroRNA-143 regulates collagen type III expression in stromal fibroblasts of scirrhous type gastric cancer. Cancer Sci. 2013; 105(2):228-35. PMC: 4317817. DOI: 10.1111/cas.12329. View

Hur H, Lee H, Jung H, Song K, Jeon H, Park C . Predicting factors of unexpected peritoneal seeding in locally advanced gastric cancer: indications for staging laparoscopy. J Surg Oncol. 2010; 102(7):753-7. DOI: 10.1002/jso.21685. View

Yook J, Oh S, Kim B . Clinicopathological analysis of Borrmann type IV gastric cancer. Cancer Res Treat. 2009; 37(2):87-91. PMC: 2785394. DOI: 10.4143/crt.2005.37.2.87. View

Kodera Y, Yamamura Y, Ito S, Kanemitsu Y, Shimizu Y, Hirai T . Is Borrmann type IV gastric carcinoma a surgical disease? An old problem revisited with reference to the result of peritoneal washing cytology. J Surg Oncol. 2001; 78(3):175-81; discussion 181-2. DOI: 10.1002/jso.1144. View

Accetta A, Ferreira Manso J, Mello E, Paiva R, Castro L, Accetta P . Type IV Borrmann gastric adenocarcinoma: analysis of curative resection results. Rev Col Bras Cir. 2011; 38(4):237-44. DOI: 10.1590/s0100-69912011000400007. View

Yamashita K, Sakuramoto S, Katada N, Kikuchi S, Watanabe M . Simple prognostic indicators using macroscopic features and age in advanced gastric cancer. Hepatogastroenterology. 2014; 61(130):512-7. View

Schauer M, Peiper M, Theisen J, Knoefel W . Prognostic factors in patients with diffuse type gastric cancer (linitis plastica) after operative treatment. Eur J Med Res. 2011; 16(1):29-33. PMC: 3351946. DOI: 10.1186/2047-783x-16-1-29. View

Li C, Oh S, Kim S, Hyung W, Yan M, Zhu Z . Macroscopic Borrmann type as a simple prognostic indicator in patients with advanced gastric cancer. Oncology. 2009; 77(3-4):197-204. DOI: 10.1159/000236018. View

10.

Kitamura K, Beppu R, Anai H, Ikejiri K, Yakabe S, Sugimachi K . Clinicopathologic study of patients with Borrmann type IV gastric carcinoma. J Surg Oncol. 1995; 58(2):112-7. DOI: 10.1002/jso.2930580208. View

11.

Morita K, Fujimori T, Ono Y, Hiraishi H, Yoshiura K, Shimada T . Identification of the prelinitis condition in gastric cancer and analysis of TGF-beta, TGF-beta RII and pS2 expression. Pathobiology. 2002; 69(6):321-8. DOI: 10.1159/000064639. View

12.

Mahara K, Kato J, Terui T, Takimoto R, Horimoto M, Murakami T . Transforming growth factor beta 1 secreted from scirrhous gastric cancer cells is associated with excess collagen deposition in the tissue. Br J Cancer. 1994; 69(4):777-83. PMC: 1968800. DOI: 10.1038/bjc.1994.147. View

13.

Oo H, Sentani K, Sakamoto N, Anami K, Naito Y, Oshima T . Identification of novel transmembrane proteins in scirrhous-type gastric cancer by the Escherichia coli ampicillin secretion trap (CAST) method: TM9SF3 participates in tumor invasion and serves as a prognostic factor. Pathobiology. 2014; 81(3):138-48. DOI: 10.1159/000357821. View

14.

Maehara Y, Moriguchi S, Orita H, Kakeji Y, Haraguchi M, Korenaga D . Lower survival rate for patients with carcinoma of the stomach of Borrmann type IV after gastric resection. Surg Gynecol Obstet. 1992; 175(1):13-6. View

15.

. Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer. 2011; 14(2):101-12. DOI: 10.1007/s10120-011-0041-5. View

16.

Pedrazzani C, Marrelli D, Pacelli F, Di Cosmo M, Mura G, Bettarini F . Gastric linitis plastica: which role for surgical resection?. Gastric Cancer. 2011; 15(1):56-60. DOI: 10.1007/s10120-011-0063-z. View

17.

Koyama T, Yashiro M, Inoue T, Nishimura S . TGF-beta1 secreted by gastric fibroblasts up-regulates CD44H expression and stimulates the peritoneal metastatic ability of scirrhous gastric cancer cells. Int J Oncol. 2000; 16(2):355-62. DOI: 10.3892/ijo.16.2.355. View

18.

Yamashita K, Hosoda K, Katada N, Moriya H, Mieno H, Higuchi K . Survival outcome of Borrmann type IV gastric cancer potentially improved by multimodality treatment. Anticancer Res. 2015; 35(2):897-906. View

19.

Yoshikawa T, Tsuburaya A, Kobayashi O, Sairenji M, Motohashi H, Noguchi Y . Should scirrhous gastric carcinoma be treated surgically? Clinical experiences with 233 cases and a retrospective analysis of prognosticators. Hepatogastroenterology. 2001; 48(41):1509-12. View